Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian G Wicha

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
JMIR Mhealth and Uhealth|April 22, 2020
Mobile Health Apps for Improvement of Tuberculosis Treatment: Descriptive ReviewLina Keutzer, Sebastian G Wicha, Ulrika Sh Simonsson
Pharmaceutical Research|January 30, 2015
Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureusSebastian G Wicha, Martin G Kees, Janin Kuss, et al.
The AAPS Journal|June 23, 2018
Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design RecommendationsChunli Chen, Sebastian G Wicha, Rikard Nordgren, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Concentration-response studies and modelling of the pharmacodynamics of linezolid: Staphylococcus aureus versus Enterococcus faeciumChristian Scheerans, Sebastian G Wicha, Julia Michael, et al.
Nature Communications|December 16, 2017
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactionsSebastian G Wicha, Chunli Chen, Oskar Clewe, et al.
Pharmaceutical Research|September 27, 2022
Optimized Rhombic Experimental Dynamic Checkerboard Designs to Elucidate Pharmacodynamic Drug Interactions of AntibioticsNiklas Kroemer, Romain Aubry, William Couet, et al.
Intensive Care Medicine|January 31, 2023
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matterUwe Liebchen, Josef Briegel, Alexander Brinkmann, et al.
British Journal of Clinical Pharmacology|October 8, 2021
Population pharmacokinetics and target attainment analysis of linezolid in multidrug-resistant tuberculosis patientsAnna K Tietjen, Niklas Kroemer, Dario Cattaneo, et al.
Clinical Pharmacokinetics|November 26, 2023
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target AttainmentIris K Minichmayr, Sebastian G Wicha, Peter Matzneller, et al.
Journal of Clinical Pharmacology|September 4, 2013
Unbound fraction of vancomycin in intensive care unit patientsMartin G Kees, Sebastian G Wicha, Astrid Seefeld, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
JMIR Mhealth and Uhealth|April 22, 2020
Mobile Health Apps for Improvement of Tuberculosis Treatment: Descriptive ReviewLina Keutzer, Sebastian G Wicha, Ulrika Sh Simonsson
Pharmaceutical Research|January 30, 2015
Pharmacodynamic and response surface analysis of linezolid or vancomycin combined with meropenem against Staphylococcus aureusSebastian G Wicha, Martin G Kees, Janin Kuss, et al.
The AAPS Journal|June 23, 2018
Comparisons of Analysis Methods for Assessment of Pharmacodynamic Interactions Including Design RecommendationsChunli Chen, Sebastian G Wicha, Rikard Nordgren, et al.
International Journal of Antimicrobial Agents|December 3, 2014
Concentration-response studies and modelling of the pharmacodynamics of linezolid: Staphylococcus aureus versus Enterococcus faeciumChristian Scheerans, Sebastian G Wicha, Julia Michael, et al.
Nature Communications|December 16, 2017
A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactionsSebastian G Wicha, Chunli Chen, Oskar Clewe, et al.
Pharmaceutical Research|September 27, 2022
Optimized Rhombic Experimental Dynamic Checkerboard Designs to Elucidate Pharmacodynamic Drug Interactions of AntibioticsNiklas Kroemer, Romain Aubry, William Couet, et al.
Intensive Care Medicine|January 31, 2023
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matterUwe Liebchen, Josef Briegel, Alexander Brinkmann, et al.
British Journal of Clinical Pharmacology|October 8, 2021
Population pharmacokinetics and target attainment analysis of linezolid in multidrug-resistant tuberculosis patientsAnna K Tietjen, Niklas Kroemer, Dario Cattaneo, et al.
Clinical Pharmacokinetics|November 26, 2023
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target AttainmentIris K Minichmayr, Sebastian G Wicha, Peter Matzneller, et al.
Journal of Clinical Pharmacology|September 4, 2013
Unbound fraction of vancomycin in intensive care unit patientsMartin G Kees, Sebastian G Wicha, Astrid Seefeld, et al.
Pageof 12